Cytosorbents Corp. Stock
Cytosorbents Corp. Stock
Cytosorbents Corp. dominated the market today, gaining €0.028 (3.260%).
Currently there is a rather positive sentiment for Cytosorbents Corp. with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 0.84 € the target price of 3 € shows a potential of 258.0% for Cytosorbents Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Cytosorbents Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Cytosorbents Corp. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cytosorbents Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cytosorbents Corp. | 3.260% | -5.524% | 8.549% | -69.360% | -14.577% | -87.658% | - |
MicroVision Inc | 2.400% | -0.659% | -20.742% | -72.024% | -58.210% | -90.762% | 46.583% |
Fonar Corp. New | 7.580% | -0.699% | -4.698% | -11.801% | -19.774% | -5.960% | -21.849% |
Allscripts Healthcare | - | 0.000% | 4.348% | -34.545% | -22.162% | -47.826% | -17.846% |
Comments
Cytosorbents Co. (NASDAQ: CTSO) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $3.00 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat
Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at B. Riley. They set a "buy" rating and a $4.00 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat
Cytosorbents Co. (NASDAQ: CTSO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Show more
Ratings data for CTSO provided by MarketBeat